Activating the dark genome to illuminate cancer vaccine targets

被引：0
|
作者：
Kwok, Darwin W. [1 ]
Okada, Hideho [1 ,2 ]
Costello, Joseph F. [1 ]
机构：
[1] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
[2] Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA
来源：
NATURE GENETICS | 2024年 / 56卷 / 09期
关键词：
DNA METHYLATION; GENES;
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Epigenetic therapy triggers myriad transposable elements to generate new antigens that could prime tumor cells for immunotherapy. A study of glioblastoma discovers indiscriminate activation in healthy cells as well, and presents a more selective strategy for potential therapeutic targeting.
引用
收藏
页码：1770 / 1771
页数：2
相关论文
共 50 条
  • [31] A new vaccine successfully targets early breast cancer tumors
    Ellis, Ronald
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (03)
  • [32] Directing Hypoxic Tumor Microenvironment and HIF to Illuminate Cancer Immunotherapy's Existing Prospects and Challenges in Drug Targets
    Ray, Suman Kumar
    Mukherjee, Sukhes
    CURRENT DRUG TARGETS, 2022, 23 (05) : 471 - 485
  • [33] Cancer development and therapy resistance: spotlights on the dark side of the genome
    Leucci, Eleonora
    PHARMACOLOGY & THERAPEUTICS, 2018, 189 : 22 - 30
  • [34] Cancer Genome Project yields new therapeutic targets for melanoma
    Bonn, D
    LANCET ONCOLOGY, 2002, 3 (08): : 452 - 452
  • [35] Genome-bound enzymes as epigenetic drug targets in cancer
    Bomsztyk, Karol
    Wang, Yuliang
    EPIGENOMICS, 2019, 11 (13) : 1463 - 1467
  • [36] Drugging the cancer genome: New challenges of infrequent and combinatorial targets
    Workman, Paul
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (06) : 445 - 446
  • [37] Classical and pleiotropic actions of dipyridamole: Not enough light to illuminate the dark tunnel?
    Balakumar, Pitchai
    Ying Hui Nyo
    Renushia, Raja
    Raaginey, Devarajan
    Ann Nah Oh
    Varatharajan, Rajavel
    Dhanaraj, Sokkalingam A.
    PHARMACOLOGICAL RESEARCH, 2014, 87 : 144 - 150
  • [38] HER2 activating mutations are potential targets for colorectal cancer treatment
    Kavuri, Shyam M.
    Jain, Naveen
    Galimi, Francesco
    Cottino, Francesca
    Searleman, Adam C.
    Shen, Wei
    Trusolino, Livio
    Jacobs, Samuel A.
    Bertotti, Andrea
    Bose, Ron
    CANCER RESEARCH, 2015, 75
  • [39] Seeing in the dark: a metagenomic approach can illuminate the drivers of plant disease
    Roman-Reyna, Veronica
    Crandall, Sharifa G.
    FRONTIERS IN PLANT SCIENCE, 2024, 15
  • [40] Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review)
    Ren, Shengnan
    Zhang, Zhanyi
    Li, Mengyuan
    Wang, Daren
    Guo, Ruijie
    Fang, Xuedong
    Chen, Fangfang
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2023, 62 (06)
12345